The Institute of Cancer Research says the disease is often heavily reliant on breaking down fats for its growth and spread.
They’re stressing that the proposed dietary changes would only apply in combination with a new class of drugs.
The institute’s CEO Professor Paul Workman says it’s an “exciting and important study”.